| product Name |
()-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide |
| Synonyms |
Bupivacaine [INN:BAN]; Bupivacaine; (+-)-Bupivacaine; 1-Butyl-2',6'-pipecoloxylidide; AH 250; Anekain; Bupivacaina; Bupivacaina [INN-Spanish]; Bupivacainum; Bupivacainum [INN-Latin]; DL-Bupivacaine; UNII-Y8335394RO; Win 11318; dl-1-Butyl-2',6'-pipecoloxylidide; (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; 2',6'-Pipecoloxylidide, 1-butyl-; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-; Bupivacaine (base and/or unspecified salts); 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; 3-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide |
| Molecular Formula |
C18H28N2O |
| Molecular Weight |
288.432 |
| InChI |
InChI=1/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21) |
| CAS Registry Number |
2180-92-9;38396-39-3 |
| EINECS |
218-553-3;253-911-2 |
| Molecular Structure |
|
| Hazard Symbols |
|
| Risk Codes |
|
| Safety Description |
|
|
